The company aims to develop antibodies and targeted proteins for therapeutic and diagnostic purposes. The development includes all steps from rational design to production and distribution, as well as related activities, including consulting, lectures, and publications. The company may establish branches in Switzerland and abroad, expand its activities to related business areas, participate in other companies, acquire, use, and sell intellectual property rights and real estate, and enter into all transactions and conclude contracts that are suitable to promote the purpose of the company directly or indirectly.